Biohaven Ltd.
BHVN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001935979
No open-market purchases or sales by Biohaven Ltd. insiders were filed in the last 90 days; 297 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Biohaven Ltd. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 180
- −3 vs. Q4 2022
- Shares held
- 67.1M
- +4.06M (+6.4%) vs. Q4 2022
- Total value
- $921.1M
- +$38.8M (+4.4%) vs. Q4 2022
- New holders
- 34
- 53 more added
- Sold out
- 37
- 48 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BHVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 297 | $2.13B |
| Q1 2026 | 279 | $1.22B |
| Q4 2025 | 275 | $1.40B |
| Q3 2025 | 266 | $1.28B |
| Q2 2025 | 251 | $1.24B |
| Q1 2025 | 267 | $2.24B |
| Q4 2024 | 258 | $3.51B |
| Q3 2024 | 257 | $4.34B |
| Q2 2024 | 228 | $2.90B |
| Q1 2024 | 245 | $4.09B |
| Q4 2023 | 220 | $3.09B |
| Q3 2023 | 188 | $1.61B |
| Q2 2023 | 189 | $1.45B |
| Q1 2023 | 180 | $921.1M |
| Q4 2022 | 183 | $882.3M |
| Q3 2022 | 277 | $9.26B |
| Q2 2022 | 330 | $8.96B |
| Q1 2022 | 306 | $7.58B |
| Q4 2021 | 284 | $8.55B |
| Q3 2021 | 250 | $8.17B |
| Q2 2021 | 223 | $5.80B |
| Q1 2021 | 225 | $4.10B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Biohaven Ltd.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,200−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −882−100.0% | Sold out |
| Shell Asset Management Co | 0 | $0 | 0.00% | −893−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Abound Wealth Management | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Zions Bancorporation, N.A. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| McElhenny Sheffield Capital Management, LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Fiduciary Alliance LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Glen Eagle Advisors, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −8−100.0% | Sold out |